Hikal Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Hikal Ltd is ₹ 178.75 as of 11 Jun 09:50 . The P/E Ratio of Hikal Ltd changed from 13.3 on March 2021 to 54.4 on March 2025 . This represents a CAGR of 32.54% over 5 yearsThe P/E Ratio of SMS Pharmaceuticals Ltd changed from 16.8 on March 2021 to 27.3 on March 2025 . This represents a CAGR of 10.20% over 5 years The Market Cap of Hikal Ltd changed from ₹ 1769 crore on March 2021 to ₹ 4933 crore on March 2025 . This represents a CAGR of 22.76% over 5 yearsThe Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 1053 crore on March 2021 to ₹ 1885 crore on March 2025 . This represents a CAGR of 12.36% over 5 years The revenue of Hikal Ltd for the Mar '26 is ₹ 526 crore as compare to the Dec '25 revenue of ₹ 497.1 crore. This represent the growth of 5.81% The revenue of SMS Pharmaceuticals Ltd for the Mar '26 is ₹ 240.52 crore as compare to the Dec '25 revenue of ₹ 214.2 crore. This represent the growth of 12.29% The ebitda of Hikal Ltd for the Mar '26 is ₹ 64.9 crore as compare to the Dec '25 ebitda of ₹ 47.5 crore. This represent the growth of 36.63% The ebitda of SMS Pharmaceuticals Ltd for the Mar '26 is ₹ 42.47 crore as compare to the Dec '25 ebitda of ₹ 47.4 crore. This represent the decline of -10.4% The net profit of Hikal Ltd changed from ₹ 5.1 crore to ₹ 14.4 crore over 8 quarters. This represents a CAGR of 68.03% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 16.37 crore to ₹ 20.96 crore over 8 quarters. This represents a CAGR of 13.15% The Dividend Payout of Hikal Ltd changed from 18.52 % on March 2021 to 10.87 % on March 2025 . This represents a CAGR of -10.11% over 5 yearsThe Dividend Payout of SMS Pharmaceuticals Ltd changed from 4.17 % on March 2021 to 5.19 % on March 2025 . This represents a CAGR of 4.47% over 5 years .

About Hikal Ltd

Hikal Limited, incorporated on July 8, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals.
The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Company has 5 manufacturing facilities across three states in India.
It supply products to customers across the globe in the US, Japan, Europe, Canada, South East Asia, LATAM, India and RoW. Apart from this, it specialize in manufacturing APIs and intermediates in pharmaceutical division.
Within pharmaceutical division, it offer human health and animal health products. Hikal commenced its first project in 1991 at its first greenfield site at M.

About SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited was incorporated in December, 1987.
The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s.
VKT Pharma Private Limited.

FAQs for the comparison of Hikal Ltd and SMS Pharmaceuticals Ltd

Which company has a larger market capitalization, Hikal Ltd or SMS Pharmaceuticals Ltd?

Market cap of Hikal Ltd is 2,194 Cr while Market cap of SMS Pharmaceuticals Ltd is 3,571 Cr

What are the key factors driving the stock performance of Hikal Ltd and SMS Pharmaceuticals Ltd?

The stock performance of Hikal Ltd and SMS Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hikal Ltd and SMS Pharmaceuticals Ltd?

As of June 11, 2026, the Hikal Ltd stock price is INR ₹178.0. On the other hand, SMS Pharmaceuticals Ltd stock price is INR ₹381.4.

How do dividend payouts of Hikal Ltd and SMS Pharmaceuticals Ltd compare?

To compare the dividend payouts of Hikal Ltd and SMS Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.